Patrice Bonfiglio notified Amarin Corporation plc on November 16, 2026 of her decision to resign as a director, effective immediately. The resignation is not the result of any disagreement with the Company on its operations, policies or practices.
AMRN · Amarin Corp Plcuk · Documents
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Third-quarter 2026 net revenue was $39.6 million, down from $49.7 million a year earlier, and net income was $245,000. A colorectal cancer trial of the drug missed its primary progression-free survival endpoint but showed a 32% lower hazard of death in overall survival.
Amarin reported total revenue, net, of $39.6 million for the three months ended September 30, 2026, down $10.1 million, or 20%, from $49.7 million a year earlier. The decrease was due primarily to a $12.3 million decline in U.S. net product revenue. Gross margin on product sales fell to 37% from 43%, mainly due to a change in customer mix.
Amarin reported third-quarter 2026 net income of $0.2 million, against a net loss of $(7.7) million a year earlier. Total net revenue fell 20% to $39.6 million. Cash and short-term investments reached $323.4 million, and the company remains debt-free.